IDEX Biometrics ASA (OSL:IDEX)
8.18
+0.08 (0.99%)
Aug 4, 2026, 4:25 PM CET
IDEX Biometrics ASA Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.14 | - | - | 11.35 | 16.12 | 33.76 |
Cash & Short-Term Investments | 0.14 | - | - | 11.35 | 16.12 | 33.76 |
Cash Growth | -86.59% | - | - | -29.60% | -52.24% | 362.58% |
Accounts Receivable | -0.01 | 0.05 | 0.03 | 0.95 | 1.35 | 0.8 |
Other Receivables | 0.34 | 0.32 | 0.9 | 0.98 | 0.93 | 0.7 |
Total Trade Receivables | 0.33 | 0.37 | 0.93 | 1.93 | 2.28 | 1.5 |
Inventory | 6.36 | 5.68 | 5.55 | 6.38 | 4.45 | 1.23 |
Other Current Assets | 0.36 | 0.29 | 0.76 | 0.65 | 0.99 | 0.85 |
Total Current Assets | 7.19 | 7.06 | 9.26 | 20.31 | 23.84 | 37.35 |
Net Property, Plant & Equipment | - | - | - | 2.59 | 2.65 | 1.66 |
Other Intangible Assets | 0.47 | 0.47 | 0.57 | 1.01 | 1.49 | 1.97 |
Goodwill | - | - | - | 0.97 | 0.97 | 0.97 |
Other Long-Term Assets | 0.06 | 0.06 | 0.06 | 0.08 | 0.07 | 0.09 |
Total Assets | 7.79 | 7.64 | 10.3 | 24.96 | 29.02 | 42.03 |
Accounts Payable | 2.11 | 1.16 | 0.85 | 0.69 | 1.54 | 0.69 |
Accrued Expenses | 0.16 | 0.07 | 0.27 | 0.28 | 0.39 | 0.39 |
Short-Term Debt | - | 1.09 | - | 5.08 | - | - |
Current Portion of Leases | - | 0.08 | 0.4 | 0.62 | 0.4 | 0.36 |
Other Current Liabilities | 6.14 | 2.06 | 1.95 | 5.72 | 2.7 | 2.85 |
Total Current Liabilities | 8.41 | 4.46 | 3.46 | 12.39 | 5.03 | 4.29 |
Long-Term Debt | - | 1.72 | 2.12 | 0 | - | - |
Long-Term Leases | - | - | - | 1.24 | 1.14 | 0.01 |
Total Long-Term Liabilities | - | 1.72 | 2.12 | 1.24 | 1.14 | 0.01 |
Total Liabilities | 8.41 | 6.18 | 5.58 | 13.63 | 6.18 | 4.3 |
Common Stock | 6.72 | 6.21 | 12.94 | 25.96 | 22.76 | 20.41 |
Additional Paid-in Capital | 3.69 | 2.71 | 348.21 | 26.98 | 27.61 | 30.87 |
Accumulated Other Comprehensive Income | -11.03 | -7.46 | -356.44 | 288.43 | 275.87 | 257.19 |
Retained Earnings | - | - | - | -330.03 | -303.4 | -270.74 |
Total Common Shareholders' Equity | -0.62 | 1.46 | 4.71 | 11.33 | 22.84 | 37.73 |
Shareholders' Equity | -0.62 | 1.46 | 4.71 | 11.33 | 22.84 | 37.73 |
Total Liabilities & Equity | 7.79 | 7.64 | 10.3 | 24.96 | 29.02 | 42.03 |
Total Debt | - | 2.89 | 2.52 | 6.94 | 1.54 | 0.37 |
Net Cash (Debt) | 0.14 | -2.89 | -2.52 | 4.41 | 14.58 | 33.39 |
Net Cash Growth | - | - | - | -69.73% | -56.33% | 435.03% |
Net Cash Per Share | 0.01 | -0.07 | -0.06 | 0.02 | 7.06 | 17.75 |
Book Value | -0.62 | 1.46 | 4.71 | 11.33 | 22.84 | 37.73 |
Book Value Per Share | -0.02 | 0.04 | 0.12 | 0.04 | 11.07 | 20.06 |
Tangible Book Value | -1.09 | 0.99 | 4.14 | 9.36 | 20.39 | 34.79 |
Tangible Book Value Per Share | -0.04 | 0.03 | 0.11 | 0.04 | 9.88 | 18.50 |